共 162 条
[11]
Baker SS(2021)Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease Comput Struct Biotechnol J 19 5920-756
[12]
Gill C(2019)Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study Hepatol Int 13 748-648
[13]
Safari Z(2020)Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD Nat Commun 11 4982-366
[14]
Gérard P(2024)Composition of gut microbiota and non-alcoholic fatty liver disease Obes Rev 25 e13646-977
[15]
Zhu L(2020)Gut microbiome, big data and machine learning to promote precision medicine for cancer Nat Rev Gastroenterol Hepatol 17 635-112
[16]
Baker RD(2021)Interpretable Diabetes Care 44 358-730
[17]
Baker SS(2022)Risk assessment with gut microbiome and metabolite markers in NAFLD development Sci Transl Med 14 eabk0855-1359
[18]
Canfora EE(2022)Higher serum vitamin A is associated with a worsened progression of non-alcoholic fatty liver disease in adults: a prospective study Food Funct 13 970-463
[19]
Meex RCR(2008)Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases J Dig Dis 9 108-7
[20]
Venema K(2019)Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study Eur J Nutr 58 721-381